Arthneeti

Nureca Q2 FY27 Share Price & Earnings Call Analysis

₹305.00+2.18% today
Market cap
₹292 Cr
P/E
67.18
ROE
1.12%
PEG
2.22
Price to sales
1.91
Debt to equity
0.01
52W high / low
₹367 / ₹207
Sales growth (5Y)
-7.19%
EBITDA margin
2.72%
Net profit margin
1.43%
Promoter holding
70.68%
Sales (last year)
₹153 Cr

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Molbio DiagnostiGood growth
    3
See all potential multibaggersWhere does Nureca Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Equipment & Supplies companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Flat₹598 Cr20.4
240%+Flat₹139 Cr15.9
3Molbio Diagnosti20–40%Flat₹14,682 Cr67.6
420–40%Flat₹160 Cr32.4
510–20%Up 2%+₹143 Cr15.9
610–20%Up 0–2%₹755 Cr62.3

Sign up free to see every company in the sector ranking and track Nureca Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Equipment & Supplies ranking

Financials of Nureca Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Nureca Ltd

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +63.24%63.24%63.24%63.78%64.06%64.30%64.33%64.97%64.97%68.09%68.09%70.68%
FIIs +0.07%0.07%0.07%0.69%0.36%1.07%0.07%0.07%0.08%0.28%0.11%0.22%
DIIs +0.00%0.00%0.00%0.00%0.04%0.04%0.04%0.04%0.04%0.24%0.24%0.24%
Public +36.69%36.69%36.69%35.53%35.54%34.59%35.56%34.92%34.91%31.39%31.57%28.85%
No. of Shareholders49,60045,99643,81341,98641,31439,30438,07537,46835,80134,55833,97931,719

Financials of Nureca Ltd

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +31.3522.3716.9720.2731.1926.4631.7434.1837.7439.6435.4140.3458.53
Expenses +29.9726.6221.4022.6333.5430.4730.5434.7434.4736.3941.1936.9253.30
Operating Profit1.38-4.25-4.43-2.36-2.35-4.011.20-0.563.273.25-5.783.425.23
OPM %4.40%-19.00%-26.10%-11.64%-7.53%-15.15%3.78%-1.64%8.66%8.20%-16.32%8.48%8.94%
Other Income +3.205.90-1.265.793.171.481.992.572.322.191.021.821.35
Interest0.080.110.180.150.270.180.620.250.460.280.300.200.26
Depreciation0.590.590.600.660.620.540.520.530.540.500.450.610.81
Profit before tax3.910.95-6.472.62-0.07-3.252.051.234.594.66-5.514.435.51
Tax %25.83%82.11%-35.86%36.64%585.71%-13.85%-20.00%34.15%21.13%19.96%10.71%30.93%26.50%
Net Profit +2.890.17-4.151.66-0.48-2.802.470.813.633.73-6.093.074.05
EPS in Rs2.890.17-4.151.66-0.48-2.802.470.813.633.91-6.383.224.24

Financials of Nureca Ltd

Profit & Loss

Annual income statement trend

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +629921325611192110147174
Expenses +5390152200126102117147168
Operating Profit9106256-15-10-806
OPM %15%10%29%22%-13%-11%-7%0.1%3.5%
Other Income +00387111286
Interest012100111
Depreciation000122222
Profit before tax996261-11-3159
Tax %30%26%26%26%-23%-30%37%58%
Net Profit +664645-8-2125
EPS in Rs623.00640.0046.3744.96-8.25-1.790.852.184.99
Dividend Payout %0%0%4%7%0%0%0%0%

Financials of Nureca Ltd

Balance Sheet

Capital structure and asset base

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital0.010.0110101010101010
Reserves815153193185183184171178
Borrowings +0104433527
Other Liabilities +1591912810111337
Total Liabilities2434186219207205210196231
Fixed Assets +114109791418
CWIP000000005
Investments000335994113
Other Assets +2333182175139104200182205
Total Assets2434186219207205210196231

Financials of Nureca Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +0-835110-3-193
Cash from Investing Activity +-0-0-110-3-1618814
Cash from Financing Activity +-0892-7-2-1-0-20
Net Cash Flow0-017-9-814-11-2
Free Cash Flow0-834-510-4-23-3
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit4%-82%81%35%-96%39%234%1,464%

Financials of Nureca Ltd

Ratios

Working capital efficiency and return ratios

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days5247641461119
Inventory Days12393135174167186214187
Days Payable8933321324313520
Cash Conversion Cycle87107109165157161190186
Working Capital Days458561109156176163145
ROCE %57%67%33%-6%-4%1%3%

Continue your research

What Nureca Ltd's management said in earlier quarters

Others in Healthcare Equipment & Supplies this season

  • Galaxy Medicare (Q2 FY27)

    Revenue from Operations (₹ Mn): . Key investor presentation takeaways from Galaxy Medicare's Q2 FY27 investor presentation — and how it ranks against sector pee

  • Aprameya Enginee (Q2 FY26)

    H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26

  • QMS Medical (Q3 FY26)

    Q3FY26 Revenue from Operations: ₹37.3 crore . Key investor presentation takeaways from QMS Medical Allied Services Ltd's Q3 FY26 investor presentation — and how

  • Vaidya Sane (Q4 FY26)

    170-180 crores driven by higher patient additions, increased hospital utilization, and franchise clinic growth. Key concall takeaways from Vaidya Sane Ayurved…

Compare:vs Molbio Diagnostivs Poly Medicurevs Sahajanand Medi